The success of TAVR has also sparked research into transcatheter solutions for other valve diseases, including mitral and ...

Advocate Sherman Hospital Care heart patient Diana Esposito, of Elgin, unfurled a giant “Bear Down” flag Sunday, Jan. 4, ...

The U.S. Federal Trade Commission (FTC) has secured a significant antitrust victory after a federal judge ruled to block ...

Edwards Lifesciences said it no longer plans to acquire JenaValve after the Federal Trade Commission moved to block the deal. A Washington, D.C., district court granted a motion from the FTC for an ...

Advocate Health Care heart patient Diana Esposito was recognized as the Chicago Bears’ special guest during the Bear Down ...

The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular ...

Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical.

Structural heart news arrived in a steady stream throughout 2025—from pivotal trials to approvals, reimbursement decisions, ...

Nicklaus Children's Heart Institute has successfully performed an innovative pulmonary heart valve repair utilizing a complex ...

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

Medical advances transform care while industry tackles sustainability challenges and skilled worker shortages.